BK
74
3
BDX
56
10
HSY
31
-6
SIG
44
-3
MAS
52
-4
SJM
9
-5
FTI
71
-7
DHI
44
-3
IBM
47
-3
PYPL
52
-2
EL
15
-3
SCHW
62
-2
VNO
46
-13
BBY
52
6
KMI
69
-2
EBAY
42
-2
BEN
50
9
MRK
17
-5
EQR
54
3
STX
45
-4
BK
74
3
BDX
56
10
HSY
31
-6
SIG
44
-3
MAS
52
-4
SJM
9
-5
FTI
71
-7
DHI
44
-3
IBM
47
-3
PYPL
52
-2
EL
15
-3
SCHW
62
-2
VNO
46
-13
BBY
52
6
KMI
69
-2
EBAY
42
-2
BEN
50
9
MRK
17
-5
EQR
54
3
STX
45
-4
Financhill
Back

Editas Medicine Vs. EyePoint Pharmaceuticals Industry Stock Comparison

Sell
40

EDIT
Editas Medicine

Last Price:
2.53
Seasonality Move:
7.77%
Buy
55

EYPT
EyePoint Pharmaceuticals

Last Price:
8.60
Seasonality Move:
27.28%
Sell
40
Editas Medicine (EDIT) is a Sell

Is Editas Medicine a Buy, Sell or Hold?

  • The current Editas Medicine [EDIT] share price is $2.66. The Score for EDIT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • EDIT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
EyePoint Pharmaceuticals (EYPT) is a Buy

Is EyePoint Pharmaceuticals a Buy, Sell or Hold?

  • The current EyePoint Pharmaceuticals [EYPT] share price is $9.17. The Score for EYPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • EYPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

EDIT Stock Price Chart

What is Editas Medicine's stock price today?

  • The Editas Medicine share price today is $2.66
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing slight selling pressure.

EYPT Stock Price Chart

What is EyePoint Pharmaceuticals's stock price today?

  • The EyePoint Pharmaceuticals share price today is $9.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing selling pressure, which indicates risk of future bearish movement.

EDIT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 35.77 Sell
Chaikin Money Flow: -833782 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.92 - 3.38) Sell
Bollinger Bands (100): (3.13 - 4.81) Sell

EYPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.24 Buy
Relative Strength Index (14 RSI): 38.26 Sell
Chaikin Money Flow: -855119 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.95 - 11.87) Sell
Bollinger Bands (100): (8.09 - 10.47) Sell

EDIT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.04 Sell
20-day SMA: 3.11 Sell
50-day SMA: 3.34 Sell
200-day SMA: 5.33 Sell
8-day EMA: 2.95 Sell
20-day EMA: 3.08 Sell
50-day EMA: 3.37 Sell
200-day EMA: 5.1 Sell

EYPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.1 Sell
20-day SMA: 11.08 Sell
50-day SMA: 9.67 Sell
200-day SMA: 14.04 Sell
8-day EMA: 10.73 Sell
20-day EMA: 10.79 Sell
50-day EMA: 10.16 Sell
200-day EMA: 11.6 Sell

Editas Medicine Earnings Growth & EDIT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and an increase next year of $0.23 per share.

EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and a decrease next year of $0.31 per share.

Editas Medicine Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

EyePoint Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):